Tucked away on Chicago’s North Side sits a cavernous wonderland where budget-savvy homeowners and apartment dwellers alike ...

Arquitos returned 82.1% net of fees and expenses in 2025, compared to 12.8% for the Russell 2000. Read more here.

Liquidia fit this approach well. Their launch may go down as one of the most successful drug launches ever. They have already taken 25% market share and are effectively expanding the market. Amazingly ...

Novo shares have surged more than 20% amid oral Wegovy’s fast start. Elsewhere, Terns opened up room for a potential ...